AI for Predicting Heart Transplant Outcomes

A recent review has highlighted the growing use of artificial intelligence (AI) in managing post-heart transplantation (HTx) and mechanical circulatory support (MCS) clinical care. This technology is particularly promising in the field of heart failure practice, where many decisions are often made based on expert opinions in the absence of high-quality data-driven evidence. 

The review specifically focused on studies that examined post-HTx care, including post-operative management and long-term outcomes. The most common data sources used for development, training, and validation of AI algorithms are the United for Organ Sharing (UNOS) and the International Society of Heart and Lung Transplantation (ISHLT) registry. The primary outcomes studied include 1-year mortality or recipients, survival time, dependence on chronic dialysis, and graft survival. The machine learning models used include neural networks, support vector machines, random forests, and gradient-boosted machines. The predictive abilities of machine learning techniques may be limited by the quality of the clinical dataset.

The evidence revealed that AI can greatly improve the prediction of mortality outcomes in this patient population. However, there are still significant limitations to the use of AI in heart failure care. For example, there is a lack of external data validation and integration of multiple data modalities. The review found that there is a need for more mature AI algorithms for clinical application and external data validation to fully realize the potential benefits of AI in managing heart failure.

REFERENCE

Al-Ani MA, Bai C, Hashky A, Parker AM, Vilaro JR, Aranda JM Jr, Shickel B, Rashidi P, Bihorac A, Ahmed MM, Mardini MT. Artificial intelligence guidance of advanced heart failure therapies: A systematic scoping review. Front Cardiovasc Med. 2023 Feb 24;10:1127716. doi: 10.3389/fcvm.2023.1127716. PMID: 36910520; PMCID: PMC9999024.

Comments

Post a Comment

Popular posts from this blog

Emerging Therapies in Heart Failure Management

Image
Heart failure is a significant global health challenge, affecting millions of people worldwide. It arises from various causes, including ischemic heart disease, hypertension, valvular abnormalities, and cardiomyopathies. The primary issue in heart failure is the heart's inability to efficiently pump blood, leading to debilitating symptoms and high mortality rates. Traditional management has focused on alleviating symptoms and enhancing cardiac function through medications and device-based interventions.  Despite the progress in conventional treatments, heart failure continues to be a clinical challenge due to complex underlying mechanisms such as neurohormonal activation, cardiac fibrosis, and cellular remodeling. Several emerging therapies could address these challenges.     Gene therapy , including gene-editing techniques like CRISPR-Cas9, for correcting genetic mutations contributing to heart failure, offers a promising avenue for addressing the root causes of this condition.  
Read more

Assessing Vascular Elasticity through Heart and Pulse Rhythms

Image
A novel inexpensive diagnostic methodology promises to enhance our understanding of vascular elasticity. This innovative approach leverages the patient's heart and pulse rhythms to assess the flexibility of blood vessels.  The elasticity of blood vessels, the ability of their walls to stretch and contract, plays a pivotal role in our cardiovascular health. When blood vessel walls become stiffer, individuals become more sensitive to fluctuations in blood pressure, making them more vulnerable to serious conditions like atherosclerosis and heart disease. The scientists at Samara University have proposed a more straightforward method for evaluating vascular elasticity. This methodology is based on the analysis of differences between the patient's heart and pulse rhythms. According to Dr. Alexander Fedotov, an associate professor at the Department of Laser and Biotechnical Systems at Samara University, "Periodic fluctuations in arterial blood pressure, known as Mayer waves, can
Read more

Wearable Technology for Predicting Postoperative Pulmonary Complications

Image
Postoperative Pulmonary Complications (PPCs) encompass a variety of lung-related issues that can arise after surgeries, especially after major operations like cardiac valve surgery. These complications range from pneumonia and respiratory failure to atelectasis (the partial or complete collapse of the lung), bronchospasm (airway constriction), pleural effusion (fluid accumulation around the lungs), and pulmonary embolism (a lung blood clot). In the rapidly advancing field of healthcare technology, wearable devices are emerging as key tools for predicting and mitigating postoperative complications. Highlighting this trend, a recent exploratory study by Wang et al. explores the potential of wearables in predicting PPCs following cardiac valve surgery. Their study, "A wearable six-minute walk-based system to predict postoperative pulmonary complications after cardiac valve surgery: an exploratory study," examines how wearable technology can be integrated into clinical settings.
Read more